Markets:

Overview

News

Currencies

International

Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

13.45 +0.06 (+0.45%)

Streaming Delayed Price Updated: 2:48 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

34 35 Next >

Psychedelics Break Out Of The Fringe Under RFK Jr’s 2025 Reset — But Did MNMD Or CMPS Own The Year? ↗

December 24, 2025

Regulatory thaw, political backing, and late-stage data are propelling psychedelic drugmakers into the biotech spotlight — with Compass Pathways and Mind Medicine leading the charge.

Via Stocktwits

Topics ETFs

MarketBeat’s Top 5 Rated Small-Cap Stocks ↗

December 22, 2025

Via MarketBeat

MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 18, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

MindMed Announces New Employee Inducement Grant

December 15, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

MindMed Announces New Employee Inducement Grants

December 01, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Reports Q3 2025 Earnings Miss Amid Accelerated Clinical Pipeline Spending ↗

November 06, 2025

MindMed reports a wider-than-expected Q3 2025 loss as it accelerates its late-stage clinical trials for MM120, targeting anxiety and depression.

Via Chartmill

Topics Earnings

MindMed (MNMD) Q3 2025 Earnings Call Transcript ↗

November 06, 2025

MindMed (MNMD) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

MindMed Reports Q3 2025 Financial Results and Business Updates

November 06, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

MindMed to Participate in Upcoming Investor Conferences

November 05, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

MindMed Announces New Employee Inducement Grant

November 03, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

November 03, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

MindMed to Report Q3 2025 Financial Results on November 6, 2025

October 30, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering

October 29, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

October 29, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

MindMed Announces New Employee Inducement Grant

October 14, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

Mind Medicine Analyst Cites Strong Phase 3 Pipeline For Anxiety, Depression ↗

October 13, 2025

Needham starts MindMed at Buy with a $28 target, citing strong Phase 3 prospects for MM120 in anxiety and depression and solid cash position.

Via Benzinga

The Insider Report: Panic Never Pays ↗

October 11, 2025

Via Benzinga

MindMed Announces New Employee Inducement Grants

September 22, 2025

From Mind Medicine Inc.

Via Business Wire

New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)

September 19, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

MindMed Announces New Employee Inducement Grants

September 08, 2025

From Mind Medicine Inc.

Via Business Wire

Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)

September 04, 2025

From Mind Medicine Inc.

Via Business Wire

MindMed to Participate in September Investor Conferences

August 28, 2025

From Mind Medicine Inc.

Via Business Wire

If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today ↗

August 12, 2025

Mind Medicine stock hasn't beaten the market over the last five years, but what comes next?

Via The Motley Fool

MindMed Announces New Employee Inducement Grants

August 11, 2025

From Mind Medicine Inc.

Via Business Wire

MindMed (MNMD) Q2 2025 Earnings Call Transcript ↗

August 11, 2025

Via The Motley Fool

Topics Earnings Initial Public Offering

MindMed Reports Strong Q2 2025 Results ↗

August 11, 2025

Via The Motley Fool

1 Reason to Buy MindMed (MNMD) ↗

August 07, 2025

The U.S. public and the nation's politicians seem to be coming around to the idea of reforming psychedelic drug laws. Looser restrictions on research would help this company.

Via The Motley Fool

Topics Cannabis Law Enforcement

MindMed (MNMD) Q2 Net Loss Jumps 625% ↗

August 01, 2025

Via The Motley Fool

Topics Intellectual Property

MindMed Reports Q2 2025 Financial Results and Business Updates

July 31, 2025

From Mind Medicine Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.